Intellia is developing a range of CRISPR-based therapies, both in vivo and ex vivo, targeting life-threatening diseases with significant unmet medical needs. Notably, Intellia’s in vivo programs are ...
In a recent study published in Heliyon, researchers explore nanotechnology-based nanomaterials as alternatives to antibiotics ...
CelluTx's Chief Executive Officer, Maurits Geerlings said, "We are very pleased to engage with BioCina for the worldwide ...
Looking to upgrade your smartphone game? Dive into our curated list of the best phones available in India, where cutting-edge ...
Mizuho raised the price target for the Terns Pharmaceuticals Inc (NASDAQ:TERN) stock to “a Buy”. The rating was released on June 22, 2023, according to finviz. The research report from ROTH MKM has ...
This data was generated and published by the Duke University Ex Vivo Organ Laboratory (DEVOL) and highlights the promise of ...
In Loving Memory of Alessandro Maieli August 20, 2006 Alessandro! Nell’ illusione che tu sei ancora vivo tra di noi, Mamma e Papa ti augurano un felice compleanno sperando che nel mondo dell’ eternita ...
Germline-targeting epitope scaffold nanoparticles elicit rare broadly neutralizing antibody (bnAb) precursors against human ...
JUAN DEBELLUK Conmemorando el décimo aniversario del fallecimiento de Juan Debelluk y en recordatorio del gran amor que dejó en nuestras vidas, expresamos nuestros mas profundos sentimientos, extra ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results